Devon Conway

1.4k total citations
63 papers, 822 citations indexed

About

Devon Conway is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Devon Conway has authored 63 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 14 papers in Rheumatology. Recurrent topics in Devon Conway's work include Multiple Sclerosis Research Studies (51 papers), Systemic Sclerosis and Related Diseases (13 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Devon Conway is often cited by papers focused on Multiple Sclerosis Research Studies (51 papers), Systemic Sclerosis and Related Diseases (13 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). Devon Conway collaborates with scholars based in United States, Canada and Switzerland. Devon Conway's co-authors include Jeffrey A. Cohen, Nicolas R. Thompson, Farren Briggs, Le H. Hua, Tyler G. Kinzy, Amer Alshekhlee, Ellen M. Mowry, Kathryn C. Fitzgerald, Deborah Miller and Daniel Ontaneda and has published in prestigious journals such as Neurology, The Lancet Neurology and Nature Reviews Neurology.

In The Last Decade

Devon Conway

54 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devon Conway United States 15 590 173 153 122 105 63 822
Andrea Werdecker Germany 2 493 0.8× 96 0.6× 118 0.8× 96 0.8× 57 0.5× 2 759
Shalom Haggiag Italy 17 376 0.6× 260 1.5× 93 0.6× 85 0.7× 131 1.2× 51 710
Rana Zabad United States 16 333 0.6× 166 1.0× 137 0.9× 75 0.6× 118 1.1× 34 722
Carolyn Goldschmidt United States 4 440 0.7× 107 0.6× 164 1.1× 69 0.6× 85 0.8× 9 773
Benjamin Turner United Kingdom 14 687 1.2× 298 1.7× 120 0.8× 195 1.6× 239 2.3× 42 933
Aurora Zanghì Italy 16 462 0.8× 169 1.0× 87 0.6× 117 1.0× 174 1.7× 50 648
Agnès Fromont France 11 430 0.7× 194 1.1× 91 0.6× 143 1.2× 84 0.8× 30 809
Marja‐Liisa Sumelahti Finland 16 653 1.1× 125 0.7× 114 0.7× 145 1.2× 98 0.9× 45 911
Johannes Lorscheider Switzerland 12 434 0.7× 145 0.8× 95 0.6× 79 0.6× 127 1.2× 28 557
E. Di Monte Italy 10 554 0.9× 187 1.1× 64 0.4× 163 1.3× 107 1.0× 14 649

Countries citing papers authored by Devon Conway

Since Specialization
Citations

This map shows the geographic impact of Devon Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devon Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devon Conway more than expected).

Fields of papers citing papers by Devon Conway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devon Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devon Conway. The network helps show where Devon Conway may publish in the future.

Co-authorship network of co-authors of Devon Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Devon Conway. A scholar is included among the top collaborators of Devon Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devon Conway. Devon Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amin, Moein, Harvey M. Tucker, Brandon Brown, et al.. (2025). Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice. Neurodegenerative Disease Management. 15(1). 27–36. 3 indexed citations
2.
Abbatemarco, Justin, Marisa McGinley, Julia O’Mahony, et al.. (2025). Navigating challenges and embracing opportunities toward achieving equitable multiple sclerosis care. Multiple Sclerosis and Related Disorders. 101. 106579–106579.
3.
Hersh, Carrie M., Devon Conway, Elias S. Sotirchos, et al.. (2024). A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network. Multiple Sclerosis and Related Disorders. 91. 105847–105847.
4.
Hersh, Carrie M., Moein Amin, Harvey M. Tucker, et al.. (2024). Real-world Effectiveness, Tolerability, and Safety of Ofatumumab at 12-month Follow-up (P9-6.014). Neurology. 102(7_supplement_1).
5.
Briggs, Farren, Devon Conway, Carrie M. Hersh, et al.. (2024). The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans. Multiple Sclerosis Journal. 31(2). 197–206. 2 indexed citations
6.
Conway, Devon, Amy B. Sullivan, & Mary Rensel. (2023). Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course. Neurologic Clinics. 42(1). 229–253. 2 indexed citations
7.
Morrow, Sarah A., Omid Mirmosayyeb, Devon Conway, et al.. (2023). Detecting isolated cognitive relapses in persons with MS. Multiple Sclerosis Journal. 29(14). 1786–1794. 7 indexed citations
8.
Abbatemarco, Justin, Daniel Ontaneda, Mary Rensel, et al.. (2023). Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients (P13-3.017). Neurology. 100(17_supplement_2). 1 indexed citations
9.
Morrow, Sarah A., Devon Conway, Tom Fuchs, et al.. (2021). Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology. Multiple Sclerosis Journal. 28(7). 1101–1111. 38 indexed citations
10.
Briggs, Farren, Devon Conway, Alessandro S. De Nadai, Daniel Ontaneda, & Douglas Gunzler. (2021). Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis. Multiple Sclerosis and Related Disorders. 51. 102912–102912. 5 indexed citations
11.
Galioto, Rachel, et al.. (2020). Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?. Multiple Sclerosis and Related Disorders. 46. 102502–102502. 5 indexed citations
12.
Hersh, Carrie M., et al.. (2020). Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(4). 2455379783–2455379783. 4 indexed citations
13.
Abbatemarco, Justin, Daniel Ontaneda, Kunio Nakamura, et al.. (2020). Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 46. 102593–102593. 8 indexed citations
14.
Baldassari, Laura, Kunio Nakamura, Brandon Moss, et al.. (2019). Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice. Multiple Sclerosis and Related Disorders. 38. 101525–101525. 15 indexed citations
15.
Hua, Le H., et al.. (2019). Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60. Multiple Sclerosis and Related Disorders. 30. 252–256. 18 indexed citations
16.
Salah, Husam M., David Majdalany, & Devon Conway. (2018). Lambl’s Excrescences – Taking the Crypto out of Cryptogenic Stroke: A Case Report and Literature Review. American Journal of Medical Case Reports. 6(10). 214–217.
17.
Conway, Devon, Nicolas R. Thompson, & Jeffrey A. Cohen. (2016). Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes. Multiple Sclerosis and Related Disorders. 9. 129–134. 2 indexed citations
18.
Conway, Devon, et al.. (2013). Adult-Onset Autosomal Dominant Leukodystrophy as a Multiple Sclerosis Mimic (P02.110). Neurology. 80(7_supplement).
19.
Conway, Devon & Jeffrey A. Cohen. (2010). Combination therapy in multiple sclerosis. The Lancet Neurology. 9(3). 299–308. 88 indexed citations
20.
Grommes, Christian, Devon Conway, Amer Alshekhlee, & Jill S. Barnholtz‐Sloan. (2010). Inverse association of PPARγ agonists use and high grade glioma development. Journal of Neuro-Oncology. 100(2). 233–239. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Werdecker Breakdown of academic impact, for papers by Shalom Haggiag Breakdown of academic impact, for papers by Rana Zabad Breakdown of academic impact, for papers by Carolyn Goldschmidt Breakdown of academic impact, for papers by Benjamin Turner Breakdown of academic impact, for papers by Aurora Zanghì Breakdown of academic impact, for papers by Agnès Fromont Breakdown of academic impact, for papers by Marja‐Liisa Sumelahti Breakdown of academic impact, for papers by Johannes Lorscheider Breakdown of academic impact, for papers by E. Di Monte
Rankless by CCL
2026